title: Should we be following anti-factor Xa levels in patients receiving prophylactic enoxaparin perioperatively?
authors.affiliation: Division of Plastic Surgery, Division of Health Services Research, University of Utah, Salt Lake City, UT. Electronic address: christopher.pannucci@hsc.utah.edu.
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Pannucci
authors.affiliation: Division of General Internal Medicine, Department of Medicine, University of Utah Molecular Medicine Program, Salt Lake City, UT; George E. Wahlen VAMC GRECC, Salt Lake City, UT.
authors.forename: Matthew T
authors.initials: MT
authors.lastname: Rondina
mesh_terms: D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D017984:Enoxaparin / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood*; D065427:Factor Xa Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008991:Monitoring, Physiologic / Q000379:methods; D061214:Patient Safety; D019990:Perioperative Care / Q000379:methods; D011183:Postoperative Complications / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D054556:Venous Thromboembolism / Q000517:prevention & control*
chemical_list: D017984:Enoxaparin; D065427:Factor Xa Inhibitors